对比剂肾病早期诊断的生物学标志物研究进展
被引量:3
摘要
对比剂肾病(contrast media induced nephropocthy,CIN)已成为住院患者急性肾损伤第三大常见病因;其发病机制十分复杂,且缺乏敏感的早期检测手段及有效的治疗措施。2011年欧洲泌尿放射学会(European Society of Urogenital Radiology,EsuR)对CIN定义为排除其他肾脏损害因素情况下,
出处
《医学临床研究》
CAS
2012年第9期1831-1834,共4页
Journal of Clinical Research
参考文献22
-
1Fulvio Stacul , Aart J. van der Molen , Peter Reimer. Con- trast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines[J]. Eur Radiol ,2011, 21(21) 2527-2541. 被引量:1
-
2Mishra J, Morri K, Ma Q, et al . Amelioration of ischemic a- cute renal injury by neutrophil gelatinase-associated lipocalin [J]. J Am Soc Nephrol ,2004, 15(12) : 3073-3082. 被引量:1
-
3Haase M, Bellomo R, Devarajan P, et al . Accuracy of neu- trophil gelatinase associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis[J]. Am J Kidney Dis , 2009, 54 (6) : 1012- 1024. 被引量:1
-
4Haase M, Devarajan P, Haase-Fielitz A. The outcome of neutrophil gelatinase associated lipocalin positive subclinical acute kidney injury: a multicenter pooled analysis of prospec- tive studies[J]. JAm Coll Cardiol ,2011 , 57(17): 1752- 1761. 被引量:1
-
5Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: Are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine [J]. Int J Cardiol ,2008,127(2) : 290-291. 被引量:1
-
6Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function : a meta-analysis[J]. Am J Kidney Dis ,2002, 40(2) : 221. 被引量:1
-
7Shaker OG, E1-Shehaby A, E1 Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing cor- onary angiography[J]. Angiology ,2010 , 61(8): 731-736. 被引量:1
-
8Briguori C, Visconti G, Rivera NV, et al . Cystatin C and contrast - induced acute kidney injury[J]. Circulation, 2010 , 121(19) : 2117-2122. 被引量:1
-
9Ribiehini F, Gambaro G, Graziani MS, et al . Comparison of serum creatinine and cystatin C for early diagnosis of con- trast-induced nephropathy after coronary angiography and in- terventions[J].CAin Chem , 2012, 58(2):458-464. 被引量:1
-
10马雪,张蓓茹,李德天.尿KIM-1蛋白诊断早期造影剂肾病的实验研究[J].南方医科大学学报,2011,31(2):357-360. 被引量:11
二级参考文献13
-
1Morcos SK,Thomsen HS,Webb JA.Contrast-media-induced nephrotoxicity:a consensus report.Contrast Media Safety Committee,European Society of Urogenital Radiology (ESUR)[J].Eur Radiol,1999,9(8):1602-1613. 被引量:1
-
2National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39(2 Suppl 1):S1-S266. 被引量:1
-
3Asif A,Epstein M.Prevention of radiocontrast-induced nephropathy[J].Am J Kidney Dis,2004,44(1):12-24. 被引量:1
-
4Idée JM,Boehm J,Prigent P,et al.Role of apoptosis in the pathogenesis of contrast media-induced nephropathy and hints for its possible prevention by drug treatment[J].Anti-Inflammatory Anti-Allergy Agents Med Chem,2006,5:139-146. 被引量:1
-
5Asif A,Preston RA,Roth D.Radiocontrast-induced nephropathy[J].Am J Ther,2003,10(2):137-147. 被引量:1
-
6Hizoh I,Haller C.Radiocontrast-induced renal tubular cell apoptosis:hypertonic versus oxidative stress[[J].Invest Radiol,2002,37(8):428-434. 被引量:1
-
7Ajami G,Derakhshan A,Amoozgar H,et al.Risk of nephropathy after consumption of nonionic contrast media by children undergoing cardiac angiography:a prospective study[J].Pediatr Cardiol,2010,31(5):668-673. 被引量:1
-
8Nayak KR,Mehta HS,Price MJ,et al.A novel technique for ultra-low contrast administration during angiography or intervention[J].Catheter Cardiovasc Interv,2010,75(7):1076-1083. 被引量:1
-
9Manske CL,Sprafka JM,Strony JT,et al.Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography[J].Am J Med,1990,89(5):615-620. 被引量:1
-
10Cigarroa RG,Lange RA,Williams RH,et al.Dosing of contrast material to prevent contrast nephropathy in patients with renal disease[J].Am J Med,1989,86(6 Pt1):649-652. 被引量:1
共引文献10
-
1王君,戴春.阿托伐他汀对大鼠造影剂肾病保护作用的实验研究[J].中华临床医师杂志(电子版),2012,6(17):5262-5265. 被引量:4
-
2周炳凤,施有为.对比剂肾病诊断进展[J].医学综述,2011,17(22):3420-3423. 被引量:3
-
3刘文娟,沈莹,夏勇.对比剂肾病的研究进展[J].中华现代护理杂志,2012,18(20):2470-2473. 被引量:8
-
4李顺宝,苑国富,李放.对比剂肾病早期肾损伤生物学标志物研究进展[J].山东医药,2015,55(3):95-97. 被引量:5
-
5单文红,于芬芬,郝娟芝,季文萱,黄俊彦.对比剂肾病大鼠肾脏GRP78与caspase-12表达及胰激肽原酶干预研究[J].中国中西医结合肾病杂志,2015,16(12):1078-1081. 被引量:1
-
6王湘.黄芪颗粒在防治脑动脉瘤介入栓塞术造影剂肾病的应用[J].齐鲁护理杂志,2016,22(5):73-74. 被引量:3
-
7曾宪勇,朱艳,董元正,王翔,武文斌.对比剂肾病中肾小管功能损伤生物标志物的研究现状[J].中国当代医药,2016,23(11):16-19. 被引量:3
-
8许小进,张清.尿NGAL和KIM-1对冠脉造影术后造影剂肾病的预测研究[J].中西医结合心脑血管病杂志,2016,14(22):2686-2689. 被引量:2
-
9李东韬,郑建勇,赵力,陈宇,曹毅,李田昌.尿微量蛋白在对比剂肾病早期肾损伤中的变化及意义[J].河北医药,2019,41(1):66-70. 被引量:5
-
10于锐,张新茹,王丹丹,何平,白瑜,田密,张蓓茹.肾损伤分子-1参与碘对比剂致人肾小管上皮细胞体系HK-2凋亡[J].基础医学与临床,2020,40(9):1206-1211. 被引量:3
同被引文献29
-
1Kagan A, Sheikh-Hamad D. Contrast-induced kidney injury:focus on modifiable risk factors and prophylactic strategies [ J ]. Clin Cardiol, 2010,33 (2) :62-66. 被引量:1
-
2Hardy J, Hambly B, Ko H, et al. Stimulation of mesangial cells by an- giotensin 1I and lipopolysaccharide crases expression of interleukin-18, but not IL-18 receptor [ J ]. Nephron Exp Nephrol, 2010,116 ( 4 ) : 63- 71. 被引量:1
-
3Odutayo A, Cherney D. Cystatin C and acute changes in glomerular fil- tration rate [ J]. Clin Nephro1,2012,78 ( 1 ) :64-75. 被引量:1
-
4Devarajan P. Biomarkers for the early detection of acute kidney injury [ J]. Curr Opifi Pediatr,2011,23 (2) : 194-200. 被引量:1
-
5Yue Du, Michael Zappitelli, Asad Mian, et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center[ J]. Pedi- atric Nephrology,2011,26 (2) :267-274. 被引量:1
-
6Tehrani S, laing C,Yellon DM, et al. Contrast-induced acute kidney in- jury following PCI [ J ]. Eur J Clin Invest, 2013,43 ( 5 ) :483-490. 被引量:1
-
7Ling W,Zhao hui N,Ben H,et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography [ J ]. Nephron Clin Pratt ,2008,108 ( 3 ) : 176-181. 被引量:1
-
8Bulent Gul CB, gullulu M, Oral B, et al. Urinary 1L-18:a marker of contrast-induced nephropathy following percutaneous coronary inter- vention? [J]. Clin Bioehem.2008.41 (7-8 ):544-547. 被引量:1
-
9Schopp JG, Iyer RS, Wang CL, et al . Allergic reactions to i odinated contrast media: premedication considerations for pa- tients at risk[J]. Emerg Radiol, 2013, 20(4): 299-306. 被引量:1
-
10Kroft LJ, Roelofs JJ, Geleijns J. Scan time and patient dose for thoracic imaging in neonates and small children using axial volumetric 320-detector row CT compared to helical 64-, 32-, and 16-detector row CT acquisitions[J]. Pediatr Radiol , 2010, 40(3): 294-300. 被引量:1
引证文献3
-
1何海燕,李文华,赵昕,刘加立,钱文浩,李东野.尿IL-18对冠状动脉介入诊疗术后对比剂肾病的早期诊断价值[J].中华全科医学,2014,12(12):1935-1937. 被引量:3
-
2林义秋,李莉,夏冬梅,范平.CTA或CTP检查患儿对比剂外渗原因分析及干预措施[J].医学临床研究,2015,32(7):1384-1385. 被引量:2
-
3赵敏,王德昭.尿微量白蛋白及血红细胞比容水平与对比剂肾病的相关性分析[J].医学临床研究,2015,32(8):1577-1578. 被引量:2
二级引证文献7
-
1冯荣杰.整体护理在预防磁共振成像对比剂过敏中的应用价值[J].中国药物经济学,2015,10(12):137-138.
-
2方文宾,王文标,梁亚非,董扬,刘俊,俞北伟.冠心病患者冠状动脉侧支生成的影响因子分析[J].中国现代医生,2016,54(7):5-7. 被引量:2
-
3方文宾,王文标,梁亚非,董扬,刘俊,俞北伟,蔡哲钧.冠状动脉侧支循环形成的影响因素Logistic回归分析[J].中国现代医生,2016,54(10):26-29. 被引量:1
-
4张丽,姚艳敏,宋巧凤,王希柱,闫玉敏,周文华.β2微球蛋白测定对急性心肌梗死PCI术后心肾功能的评价意义[J].医学临床研究,2016,33(6):1162-1164. 被引量:3
-
5李然,王德良.预测冠脉介入诊疗术后对比剂肾病中应用CMV和CrCl比值的重要价值[J].中国中西医结合肾病杂志,2017,18(10):882-884. 被引量:1
-
6庞程,朱楠.CT增强扫描碘造影剂外渗的防治和护理进展[J].世界复合医学,2018,4(1):93-95. 被引量:5
-
7徐容,曹入双,杨茂,林奉康,甘仲霖.低碳水化合物饮食对小鼠肾脏和肝脏的影响[J].食品安全导刊,2021(27):91-94. 被引量:4
-
1曹广亚,周运恒.急性肾损伤的早期检测标志物研究进展[J].检验医学,2011,26(4):281-284. 被引量:2
-
2李宁,任长虹,吉训明.脑外伤生物标记物的研究进展[J].中国医药,2012,7(9):1188-1190. 被引量:4
-
3王瑜元(综述),陆福明(审校).慢性移植物肾病生物学标志物的研究进展[J].国际泌尿系统杂志,2009,29(3):385-387.
-
4苏圆圆,廖晓辉.新型急性肾损伤标志物在慢性肾脏病中的作用[J].现代医药卫生,2015,31(13):1971-1973.
-
5吴建华,范亚平.梗阻性肾病肾损伤生物标志物研究进展[J].国际泌尿系统杂志,2015,35(6):958-960. 被引量:3
-
6吴建华(综述),范亚平(审校).心肾综合征相关生物标志物[J].国际泌尿系统杂志,2013,33(4):567-572.
-
7张冲,向军军.电针与干细胞移植治疗脊髓损伤的研究进展[J].中西医结合心脑血管病杂志,2016,14(20):2390-2393.
-
8吴晓云,瞿晓红,臧旺福.心脏术后急性肾损伤早期监测的新生物学指标[J].国际检验医学杂志,2009,30(3):260-261. 被引量:2
-
9王准,韩建阁,施乙飞.非体外循环和体外循环下冠状动脉旁路移植术患者术后认知功能的比较[J].中华麻醉学杂志,2009,29(1):86-87. 被引量:9
-
10徐欣晖,钱家麒.生物标志物与急性肾功能衰竭早期预测[J].国外医学(泌尿系统分册),2005,25(2):223-226.